Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

TRVI

Trevi Therapeutics Inc

May 29 • 04:00PM ET

14.14

-0.31 -2.15 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: KYMR INCY RYTM APGE NUVL VKTX AXSM BMRN KRYS NBIX

| Held by: VTI IWM VXF IWO IBB SCHA XPH VTWO IHE VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.32	Insider Own	34.77%	Shs Outstand	128.41M	Perf Week	-0.14%
Market Cap	2.01B	Forward P/E	-	EPS next Y	-0.59	Insider Trans	0.00%	Shs Float	92.62M	Perf Month	2.32%
Enterprise Value	1.84B	PEG	-	EPS next Q	-0.11	Inst Own	70.56%	Short Float	14.35%	Perf Quarter	18.62%
Income	-45.61M	P/S	-	EPS this Y	-47.34%	Inst Trans	3.37%	Short Ratio	8.79	Perf Half Y	24.47%
Sales	0.00M	P/B	10.55	EPS next Y	-25.23%	ROA	-31.83%	Short Interest	13.29M	Perf YTD	12.94%
Book/sh	1.34	P/C	11.69	EPS next 5Y	-29.80%	ROE	-33.59%	52W High	16.12 -12.28%	Perf Year	122.33%
Cash/sh	1.21	P/FCF	-	EPS past 3/5Y	11.11% 29.44%	ROIC	-26.44%	52W Low	5.38 162.82%	Perf 3Y	481.89%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	3.36% 5.13%	Perf 5Y	563.85%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	27.89%	Oper. Margin	-	ATR (14)	0.72	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	24.75	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	50.66	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	24.75	EPS Q/Q	-3.07%	SMA20	-1.18%	Beta	1.05	Target Price	24.36
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	4.57%	Rel Volume	0.66	Prev Close	14.45
Employees	34	LT Debt/Eq	0.00	Earnings	May 05 AMC	SMA200	24.64%	Avg Volume	1.51M	Price	14.14
IPO	May 07, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	-18.89% -	Trades		Volume	1,005,262	Change	-2.15%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)